Tags
- 1B
- 3000
- 3B
- 80 Million
- A
- Acute
- Acute myeloid leukemia
- Allosteric modulator
- Allosteric regulation
- An
- Antigen
- Applied Digital Data Systems
- Arm
- Armed
- Asset
- Autotaxin
- Backer
- Biobank
- Biotechnology
- Board of directors
- Breast
- Breast cancer
- Build Up
- Buildup
- Bulthuis
- Cancer
- Cancer Cell
- Candidate
- Capital
- Cash
- Cell
- Cells
- Chemotherapy
- Class
- Class II
- Clinic
- Colorectal cancer
- Combination
- Combined
- Council
- Demonstration
- Described
- Develop
- Drug
- Efficacy
- EIC
- European
- European Innovation Council
- Euros
- Expression
- Eye
- Eye neoplasm
- Eyes
- Focus
- Founding
- Fund
- Goal
- Health
- Hematology
- Hla Cla
- Human leukocyte antigen
- Include
- Indication
- Inhibitor
- Innovation
- Investment
- Investment company
- Kidney
- Kidney cancer
- Large intestine
- Launching
- Leukemia
- Long term
- Lung cancer
- M
- Medicine
- Melanoma
- Metástasis
- Metastatic pancreatic cancer
- Modulation
- Modulator
- Myelofibrosis
- Myeloid
- Myeloid leukemia
- New
- New Level
- No
- Ovarian cancer
- Ovary
- Over
- Pancreas
- Pancreatic cancer
- Paresh Vyas
- Parked
- Partner
- Partners
- Pathway
- Patient
- Peptide
- Peptides
- Phase
- PHD
- Pipeline
- Portfolio
- Precision
- Pre-clinical development
- Presenting
- Primary
- Professor
- Promising
- Prostate
- Prostate cancer
- Put
- Range
- Roel Bulthuis
- Safety
- Sample
- Schroders
- Schroeder
- Second
- Serie A
- Series and parallel circuits
- Series A round
- Solubility
- Spun
- Spun Out
- Stake
- Surface
- Syncona
- Target
- Targeting
- The Clinic
- The european
- The first
- The other
- Therapy
- The work
- Total
- Treat
- Trial
- Trials
- University
- University of Oxford
- Uveal melanoma
- Venture
- Venture capital financing
- Venture round
- Vulgar Display of Power
- Vyas Phd
- Well known
- White blood cell
- Who
- Yellowstone